| Egypt | Turkey | Austria | |
| Thyroid resection | - | from $3,500 | from $10,000 |
| Stomach cancer surgery | - | from $22,320 | from $30,000 |
| Removal of spinal cord tumor | - | from $9,650 | from $50,000 |
| Removal of liver cancer | - | from $10,800 | from $40,000 |
| Removal of colon cancer | - | from $14,400 | from $20,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Oncology treatment upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Oncology treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Oncology treatment journey.
Dr. Osama Abdel Mohimen Mohamed is Head of the Hematology Unit at Shefaa Al Orman Oncology Hospitals. He is also a consultant in medical oncology and hematology at Shefa El Orman Hospital (NGO), Luxor (2019–present).
He diagnoses and treats acute and chronic leukemia, lymphoma, myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms. He also manages complications of solid tumors.
Background: He served at the National Cancer Institute, Cairo University, as a medical oncology resident, then demonstrator and assistant lecturer (2008–2022). Earlier, he was a house officer (2006–2007). He also held specialist roles at Al Salam International, Al Molalmen, and BAHEYA Oncology Center (NGO).
Memberships: ESMO (2008–present). American Society of Bone Marrow Transplantation (2009). ASH (2010).
Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.
She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.
Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.
He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.
Member: Egyptian Cancer Society, ESTRO, ESMO.
Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.
He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.
Written by Kateryna Zamkovska
Written by Anna Leonova
Written by Anna Shchur
Written by Kateryna Zamkovska
Written by Kateryna Zamkovska
Egyptian oncologists frequently hold prestigious international certifications and undergo extensive training abroad. Many specialists are members of the European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO). Leading doctors often complete fellowships in the UK, Germany, Italy, and France.
Bookimed Expert Insight: Data shows a strong trend of Egyptian oncologists returning from top-tier European institutes to lead local specialized units. For example, Dr. Emad Shash and Dr. Tamer Mostafa Manie both gained expertise at the European Institute of Oncology in Milan. This allows patients to access European-standard surgical techniques, like super microsurgery for lymphedema, within Cairo-based clinics.
Patient Consensus: Patients note it is important to ask doctors directly about their specific international memberships. They often look for certifications from the UK Royal College or ESMO to verify a specialist's global training background.
Onced oncology centers in Egypt maintain safety through international protocols and specialized expertise. Facilities like Shefa Al Orman Comprehensive Cancer Center use advanced technologies including VMAT and SRS. Many Egyptian oncologists hold prestigious European and American fellowships, ensuring treatment alignment with Western medical standards.
Bookimed Expert Insight: A major safety signal is the collaboration between different institutions. Professors from the National Cancer Institute in Cairo often lead departments at regional centers like Shefa Al Orman. This ensures that even centers outside the capital benefit from the country's most rigorous academic and safety oversight.
Patient Consensus: Patients emphasize the need to verify equipment calibration and international drug suppliers before starting. They suggest requesting written treatment plans in English to help coordinate long-term monitoring with doctors abroad.
Egypt hosts several oncology facilities that maintain international standards and serve a growing number of foreign patients. Centers like Cairo Plastic Clinic hold ISO 45001:2018 certifications. Leading hospitals utilize advanced technologies including image-guided brachytherapy and supermicrosurgery for lymphedema. Expert oncologists often hold memberships in the European Society for Medical Oncology.
Bookimed Expert Insight: Data shows that Egyptian oncology centers often bridge the gap between high-volume clinical practice and academic research. For example, Dr. Emad Shash has participated in 70+ international clinical trials. This level of involvement ensures patients access updated systemic therapies, such as the latest targeted and immunotherapy protocols, usually found only in major European hubs.
Patient Consensus: Patients note that private hospitals with JCI status offer smoother experiences with English-speaking staff. They suggest coordinating with local contacts if choosing public centers to better navigate administrative steps.
Recovery timelines in Egypt vary by treatment type. Patients typically require 6 to 8 weeks after major surgery before they are fit for international travel. Chemotherapy cycles usually necessitate 2 to 4 weeks of local stay to monitor for side effects and manage fatigue.
Bookimed Expert Insight: Oncology specialists in Egypt, like Dr. Emad Shash or Dr. Tamer Mostafa Manie at the National Cancer Institute, often work within multidisciplinary teams. Our data shows that clinics in Cairo serving 1,500+ annual patients typically have faster pathology turnaround. Patients should budget for 50% extra stay time to account for these results or potential clearance delays.
Patient Consensus: Patients note it is vital to coordinate with a home doctor before traveling to Egypt. Many suggest extending stay dates because final follow-up scans often happen just as original flights are scheduled to depart.
Immunotherapy and targeted drugs are routinely available in Egypt at specialized oncology centers and private clinics. Facilities like the National Cancer Institute (NCI) in Cairo provide modern treatments. Molecular testing is available through established laboratory chains. Surgeons often recommend confirmatory testing for complex genetic mutations.
Bookimed Expert Insight: Clinical oncology in Egypt is highly centralized in Cairo. Experts like Dr. Emad Shash, who manages the Breast Comprehensive Cancer Hospital, often oversee both clinical trials and private practice. This dual role allows patients to access newer drugs that might otherwise be out of stock in smaller regional facilities.
Patient Consensus: Patients note that while major drugs are available in Cairo, supply can be inconsistent in smaller cities. Many recommend verifying drug authenticity and considering a second opinion on molecular lab results for high-stakes cases.
Medical tourists usually stay 6 to 10 weeks in Egypt for a full radiotherapy course. This timeframe covers 20 to 40 treatment sessions for breast or prostate cancer. It also includes pre-treatment consultations and recovery. Most patients receive daily radiation, 5 days per week, over 4 to 8 weeks.
Bookimed Expert Insight: Coordination is key for long-term stays in Cairo. Top specialists like Dr. Mohamed Mahmoud Abdelhakim utilize advanced VMAT and IMRT techniques. These modern technologies can sometimes allow for hypofractionated schedules. This could potentially reduce the number of required visits for certain breast cancer cases.
Patient Consensus: Patients recommend booking accommodation with kitchen facilities for stays lasting 2 months. They also suggest packing loose clothing and specific skincare products to manage skin reactions during the final weeks of treatment.
Most Egyptian oncology specialists speak fluent English due to international training. Medical records and treatment plans at major private centers are typically provided in English. Facilities like Cairo Plastic Clinic and Shefa Al Orman Comprehensive Cancer Center frequently treat international patients from Europe and the USA.
Bookimed Expert Insight: While doctors are highly proficient, a notable gap exists with bedside staff. Clinics like Cairo Plastic Clinic, which serves 1,500 international patients annually, usually have better-prepared support teams. Choosing a facility with a high volume of foreign patients typically results in a smoother communication experience throughout the recovery process.
Patient Consensus: Patients note that while surgeons are easy to understand, having a translation app is vital for talking to nurses. It is often recommended to bring a bilingual relative or arrange a private interpreter to avoid missing small details about medication and post-op care.